Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks

Kenvue Inc. (NYSE:KVUE) is included among the 10 Best NYSE Dividend Stocks to Buy.

Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks

Kenvue Inc. (NYSE:KVUE) produces and sells consumer health products across several categories, including over-the-counter medicines, personal care, and wellness items. Its portfolio features well-known household brands such as Tylenol for pain and fever relief, Neutrogena for skin care, and Listerine for oral hygiene.

Following its separation from Johnson & Johnson in 2023, Kenvue Inc. (NYSE:KVUE) has concentrated on using digital tools and consumer insights to strengthen brand relevance. At the same time, it is working to modernize its supply chain and ensure ongoing compliance with regulations. Recent initiatives highlight productivity improvements, stronger operating margins, and selective investments in digital marketing and product innovation.

After its separation from Johnson & Johnson, Kenvue Inc. (NYSE:KVUE) inherited the status of being recognized as a Dividend King. The company offers a quarterly dividend of $0.2075 per share, having raised it by 1.2% in July. With a dividend yield of 4.53%, as of September 20, KVUE is among the best dividend stocks on our list.

While we acknowledge the potential of KVUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KVUE and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 12 Best Dividend Paying Stocks to Buy Now and 13 Incredibly Cheap Dividend Stocks to Invest In.

Disclosure: None.